RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @m0370: リキッドバイオプシーはcfDNAよりエクソソームDNAを用いるほうが早期の膵癌を検出できるよという話。cfDNAは細胞死や腫瘍壊死を反映するのでexoDNAより進行しないと血中で増えないのでは、と。 /Ann Oncol https://t.co/wyAn…
RT @m0370: リキッドバイオプシーはcfDNAよりエクソソームDNAを用いるほうが早期の膵癌を検出できるよという話。cfDNAは細胞死や腫瘍壊死を反映するのでexoDNAより進行しないと血中で増えないのでは、と。 /Ann Oncol https://t.co/wyAn…
RT @m0370: リキッドバイオプシーはcfDNAよりエクソソームDNAを用いるほうが早期の膵癌を検出できるよという話。cfDNAは細胞死や腫瘍壊死を反映するのでexoDNAより進行しないと血中で増えないのでは、と。 /Ann Oncol https://t.co/wyAn…
リキッドバイオプシーはcfDNAよりエクソソームDNAを用いるほうが早期の膵癌を検出できるよという話。cfDNAは細胞死や腫瘍壊死を反映するのでexoDNAより進行しないと血中で増えないのでは、と。 /Ann Oncol https://t.co/wyAnSZN5Om
RT @Annals_Oncology: Comparison of exosome-derived DNA #exoDNA to #cfDNA in liquid biopsies of patients with early pancreatic cancer https:…
RT @Annals_Oncology: Comparison of exosome-derived DNA #exoDNA to #cfDNA in liquid biopsies of patients with early pancreatic cancer https:…
Comparison of exosome-derived DNA #exoDNA to #cfDNA in liquid biopsies of patients with early pancreatic cancer https://t.co/D9ms8l8jnO
Comparison of exosome-derived DNA #exoDNA to #cfDNA in liquid biopsies of patients with early pancreatic cancer https://t.co/D9ms8l8jnO
RT @Aiims1742: 2 independent studies @MDAndersonNews find subset of "healthy" controls have Kras mutations https://t.co/10cJlIMLwB https://…
RT @Aiims1742: 2 independent studies @MDAndersonNews find subset of "healthy" controls have Kras mutations https://t.co/10cJlIMLwB https://…
RT @Aiims1742: 2 independent studies @MDAndersonNews find subset of "healthy" controls have Kras mutations https://t.co/10cJlIMLwB https://…
2 independent studies @MDAndersonNews find subset of "healthy" controls have Kras mutations https://t.co/10cJlIMLwB https://t.co/JsvW9APLz4
RT @NatRevClinOncol: Higher %age of pts with localized PDAC had detectable KRAS mutations in exosomal DNA than reported for cfDNA https://t…
RT @NatRevClinOncol: Higher %age of pts with localized PDAC had detectable KRAS mutations in exosomal DNA than reported for cfDNA https://t…
RT @NatRevClinOncol: Higher %age of pts with localized PDAC had detectable KRAS mutations in exosomal DNA than reported for cfDNA https://t…
Higher %age of pts with localized PDAC had detectable KRAS mutations in exosomal DNA than reported for cfDNA https://t.co/OLuBuHDdVk #PancSM
RT @jsoriamd: Exosomal DNA detects KRAS mutation in pancreatic cancer pts but also healthy volunteers @Annals_Oncology @Aiims1742 https://t…
RT @jsoriamd: Exosomal DNA detects KRAS mutation in pancreatic cancer pts but also healthy volunteers @Annals_Oncology @Aiims1742 https://t…
RT @gedefo_sefh: "High Prevalence of Mutant KRAS in Circulating Exosome-derived DNA from Early Stage Pancreatic Cancer Patients" https://t.…
RT @jsoriamd: Exosomal DNA detects KRAS mutation in pancreatic cancer pts but also healthy volunteers @Annals_Oncology @Aiims1742 https://t…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @jsoriamd: Exosomal DNA detects KRAS mutation in pancreatic cancer pts but also healthy volunteers @Annals_Oncology @Aiims1742 https://t…
RT @jsoriamd: Exosomal DNA detects KRAS mutation in pancreatic cancer pts but also healthy volunteers @Annals_Oncology @Aiims1742 https://t…
"High Prevalence of Mutant KRAS in Circulating Exosome-derived DNA from Early Stage Pancreatic Cancer Patients" https://t.co/wGpYeV3W6B
RT @jsoriamd: Exosomal DNA detects KRAS mutation in pancreatic cancer pts but also healthy volunteers @Annals_Oncology @Aiims1742 https://t…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @jsoriamd: Exosomal DNA detects KRAS mutation in pancreatic cancer pts but also healthy volunteers @Annals_Oncology @Aiims1742 https://t…
RT @jsoriamd: Exosomal DNA detects KRAS mutation in pancreatic cancer pts but also healthy volunteers @Annals_Oncology @Aiims1742 https://t…
RT @jsoriamd: Exosomal DNA detects KRAS mutation in pancreatic cancer pts but also healthy volunteers @Annals_Oncology @Aiims1742 https://t…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: Just in time for #GI17 Our @Annals_Oncology paper on #LiquidBiopsy using #PancreaticCancer exosomes https://t.co/JsvW9APLz4…
Exosomal DNA detects KRAS mutation in pancreatic cancer pts but also healthy volunteers @Annals_Oncology @Aiims1742 https://t.co/C0ttMUcqGe
"Mutant KRAS exoDNA was detected in 43.6% of early-stage [pancreatic adenocA] patients and 20% of healthy controls" (!) Caveat emptor #GI17 https://t.co/pCk9YB86Fu
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
Mutant KRAS may limit #liquidbiopsy as a cancer screening tool for pancreatic cancer https://t.co/vEySELGVRC
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
RT @Aiims1742: For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in cir…
For those using liquid Bx for "cancer detection" "A substantial minority of healthy samples demonstrated mutant KRAS in circulation" #GI17 https://t.co/j5c3qsjJde
Just in time for #GI17 Our @Annals_Oncology paper on #LiquidBiopsy using #PancreaticCancer exosomes https://t.co/JsvW9APLz4 @jsoriamd